Novel sphingomyelin biomarkers for brain glioma and associated regulation research on the PI3K/Akt signaling pathway.

Zhai, Xiao-Hui; Xiao, Jian; Yu, Jie-Kai; Sun, Hong; Zheng, Shu

Zhai, Xiao-Hui; Xiao, Jian; Yu, Jie-Kai; Sun, Hong; Zheng, Shu.

Afiliación

Zhai XH; Department of Medical Oncology, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510655, P.R. China.
Xiao J; Cancer Institute, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China.
Yu JK; Department of Medical Oncology, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510655, P.R. China.
Sun H; Cancer Institute, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China.
Zheng S; Department of Chemistry and Biochemistry, University of Nevada, Las Vegas, NV 89135, USA.

Oncol Lett ; 18(6): 6207-6213, 2019 Dec.

Article en En | MEDLINE | ID: mdl-31788096

Palabras clave

PI3K/Akt signaling pathway; glioma; lipid biomarkers; matrix assisted laser desorption/ionization-imaging; sphingomyelin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncol Lett Año: 2019 Tipo del documento: Article